Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig
- PMID: 10700465
- DOI: 10.1093/intimm/12.3.305
Mapping the B cell superantigen binding site for HIV-1 gp120 on a V(H)3 Ig
Abstract
The emerging class of B cell superantigens includes HIV-1 gp120, which binds to many members of the V(H)3 Ig gene family. The present study addresses the structural features of V(H)3 antibodies conferring gp120 binding activity using a panel of recombinant full-length and Fab Ig proteins. Binding activity was fully conferred by the Fab portion of the Ig molecule. The V(H) region was the major determinant of binding; diverse light chains were permissive for gp120 binding. A series of recombinant V(H)3-V(H)1 chimeric molecules was created to analyze the contribution of different subregions of V(H)3 to gp120 binding. Hypervariable loop 1 (H1) substitution alone caused a 10-fold reduction in binding activity. The framework subregions (FR1, FR2 and FR3) and H2 also influenced binding, since substitutions of various combinations of these subregions conferred 10- to 100-fold binding reductions. We conclude that gp120 binding occurs through a non-conventional interaction involving multiple discontinuously arrayed residues spanning the V(H), and including roles in gp120 contact and favorable conformation of the V(H).
Similar articles
-
Structural basis of the gp120 superantigen-binding site on human immunoglobulins.J Immunol. 1998 Dec 15;161(12):6681-8. J Immunol. 1998. PMID: 9862697
-
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition.Science. 2003 Jun 27;300(5628):2065-71. doi: 10.1126/science.1083182. Science. 2003. PMID: 12829775
-
Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.AIDS Res Hum Retroviruses. 2003 Jul;19(7):597-607. doi: 10.1089/088922203322230969. AIDS Res Hum Retroviruses. 2003. PMID: 12908937
-
Tracking immunoglobulin variable-gene expression in HIV infection.Appl Biochem Biotechnol. 2000 Jan-Mar;83(1-3):13-28; discussion 28-9, 145-53. doi: 10.1385/abab:83:1-3:13. Appl Biochem Biotechnol. 2000. PMID: 10826946 Review.
-
B cell superantigens in HIV-1 infection.Int Rev Immunol. 1997;14(4):339-49. doi: 10.3109/08830189709116524. Int Rev Immunol. 1997. PMID: 9186785 Review.
Cited by
-
Post-Transformation IGHV-IGHD-IGHJ Mutations in Chronic Lymphocytic Leukemia B Cells: Implications for Mutational Mechanisms and Impact on Clinical Course.Front Oncol. 2021 May 25;11:640731. doi: 10.3389/fonc.2021.640731. eCollection 2021. Front Oncol. 2021. PMID: 34113563 Free PMC article.
-
Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.J Biol Chem. 2009 Oct 30;284(44):30627-42. doi: 10.1074/jbc.M109.032185. Epub 2009 Sep 2. J Biol Chem. 2009. PMID: 19726674 Free PMC article.
-
CD4 binding determinant mimicry for HIV vaccine design.Front Immunol. 2012 Dec 17;3:383. doi: 10.3389/fimmu.2012.00383. eCollection 2012. Front Immunol. 2012. PMID: 23251137 Free PMC article.
-
Metal-dependent amyloid β-degrading catalytic antibody construct.J Biotechnol. 2014 Jun 20;180:17-22. doi: 10.1016/j.jbiotec.2014.03.026. Epub 2014 Apr 1. J Biotechnol. 2014. PMID: 24698848 Free PMC article.
-
The invasin D protein from Yersinia pseudotuberculosis selectively binds the Fab region of host antibodies and affects colonization of the intestine.J Biol Chem. 2018 Jun 1;293(22):8672-8690. doi: 10.1074/jbc.RA117.001068. Epub 2018 Mar 13. J Biol Chem. 2018. PMID: 29535184 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources